Overexpression <i>TRIM37</i> inhibits inflammatory infiltration and alleviates demyelination in EAE model mice. حسب Lai Jiang (2401513)

الموضوعات:

Additional file 6 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study حسب Juliane Schikora (20871169)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

"…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …"

Change in influenza vaccination uptake from May 2020 to October 2024 (weighted). حسب Hannah Melchinger (20234665)

الموضوعات:

The Laboratory Animal Flow Diagram. حسب Xueqin lu (22250795)

الموضوعات:

¹H NMR spectra for kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

¹³C NMR spectra for Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

The structures of T3 and Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

Synthesis process of Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

ESI-HRMS spectra for Kylo-0603. حسب Xueqin lu (22250795)

الموضوعات:

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. حسب Xueqin lu (22250795)

الموضوعات:

General procedure for the synthesis of B. حسب Xueqin lu (22250795)

الموضوعات:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. حسب Xueqin lu (22250795)

الموضوعات:

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. حسب Xueqin lu (22250795)

الموضوعات:

The trends of cholesterol metabolism-related gene expression in liver tissue. حسب Xueqin lu (22250795)

الموضوعات:

Kylo-0603’s EC50 & tissue levels. حسب Xueqin lu (22250795)

الموضوعات:

DIO Mice Liver Staining. حسب Xueqin lu (22250795)

الموضوعات:

The Fibrosis scoring by Sirius Red staining and SHG/TPEF. حسب Xueqin lu (22250795)

الموضوعات:

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). حسب Xueqin lu (22250795)

الموضوعات:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. حسب Xueqin lu (22250795)

الموضوعات: